با برنامه Player FM !
Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
Manage episode 386763409 series 3256997
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including:
- Navitoclax (BCL-XL/BCL-2 inhibitor)
- Pelabresib (BET inhibitor)
- Imetelstat (telomerase inhibitor)
- Luspatercept (erythroid maturation agent)
- Additional strategies
Presenter:
Jacqueline S. Garcia, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
Link to the full program here. https://bit.ly/47z8WCV
185 قسمت
Manage episode 386763409 series 3256997
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including:
- Navitoclax (BCL-XL/BCL-2 inhibitor)
- Pelabresib (BET inhibitor)
- Imetelstat (telomerase inhibitor)
- Luspatercept (erythroid maturation agent)
- Additional strategies
Presenter:
Jacqueline S. Garcia, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
Link to the full program here. https://bit.ly/47z8WCV
185 قسمت
Kaikki jaksot
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.